RNS Number : 9166X
Alliance Pharma PLC
02 September 2015
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

ALLIANCE PHARMA PLC     

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

√

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to the
notification obligation:

NIGEL WRAY     

4. Full name of shareholder(s)
 (if different from 3.):

PERSHING NOMINEES LIMITED     

ROY NOMINEES LIMITED  

5. Date of the transaction and date on
which the threshold is crossed or
reached:

28th August 2015

6. Date on which issuer notified:

1st September 2015

7. Threshold(s) that is/are crossed or
reached:

14%

     
 

 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary shares GB0031030819

40,176,510

40,176,510

15,511,922

15,511,922

22,164,588

5.86%

8.38%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

37,676,510

 

14.24%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

Nigel William Wray has a beneficial interest in shares in Alliance Pharma Plc held by the following nominees

Pershing Nominees Limited 15,511,922

The family of Nigel Wray maintains a beneficial interest in the shares held by Roy Nominees Limited   - 22,164,588

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A

 


13. Additional information:


Figures are based on a total number of voting rights of 264,080,873

 

14. Contact name:

Nigel Wray

15. Contact telephone number:

020 7647 7647

   

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAXNAEEESEFF